Low-dose neostigmine to antagonise shallow atracurium neuromuscular block during inhalational anaesthesia: A randomised controlled trial

European Journal of Anaesthesiology

Volumn 30, Issue 10, 2013, Pages 594-598

  Fuchs Buder, Thomas ^a   Baumann, Cedric ^a   De Guis, Julien ^b   Guerci, Philippe ^b   Meistelman, Claude ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b Department of Anaesthesia and Critical Care ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM BESILATE; DESFLURANE; NEOSTIGMINE; SODIUM CHLORIDE; CHOLINESTERASE INHIBITOR; INHALATION ANESTHETIC AGENT; ISOFLURANE; NEUROMUSCULAR BLOCKING AGENT;

ACCELEROMYOGRAPHY; ADULT; ANESTHESIA INDUCTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INHALATION ANESTHESIA; MALE; MYOGRAPHY; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR MONITORING; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; UNIVERSITY HOSPITAL; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANESTHETIC RECOVERY; CONVALESCENCE; FRANCE; MIDDLE AGED; PROCEDURES; TIME; TREATMENT OUTCOME;

ADULT; ANESTHESIA RECOVERY PERIOD; ANESTHESIA, INHALATION; ANESTHETICS, INHALATION; ATRACURIUM; CHOLINESTERASE INHIBITORS; FEMALE; FRANCE; HOSPITALS, UNIVERSITY; HUMANS; ISOFLURANE; MALE; MIDDLE AGED; NEOSTIGMINE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR MONITORING; NEUROMUSCULAR NONDEPOLARIZING AGENTS; RECOVERY OF FUNCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84884476598     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e3283631652     Document Type: Article

References (29)

1. Eriksson LI, Sato M, Severinghaus JW. Effect of vecuronium-induced partial neuromuscular partial neuromuscular block on hypoxic ventilatory response. Anesthesiology 1993; 78:693-699. (Pubitemid 23110043)
2. Eikermann M, Blobner M, Groeben H, et al. Postoperative upper airway obstruction after recovery of the train of four ratio of the adductor pollicis muscle from neuromuscular blockade. Anesth Analg 2006; 102:937-942.
3. Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology 2003; 98:1042-1048. (Pubitemid 36520189)
4. Schreiber JU, Mucha E, Fuchs-Buder T. Residual paralysis following a single dose of atracurium: results from a quality assurance trial. Eur J Anaesthesiol 2010; 27:993-994.
5. Murphy GS, Szokol JW, Marymont JH, et al. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 2008; 107:130-137.
6. Sauer M, Stahn A, Soltezs S, et al. The influence of residual neuromuscular block on the incidence of critical respiratory events. A randomised, prospective, placebo-controlled trial. Eur J Anaesthesiol 2011; 28:842-848.
7. Eikermann M, Vogt FM, Herbstreit F, et al. The predisposition to inspiratory upper airway collapse during partial neuromuscular blockade. Am J Respir Care Med 2007; 175:9-15. (Pubitemid 46105303)
8. Herbstreit F, Peters J, Eikermann M. Impaired upper airway integrity by residual neuromuscular blockade: increased airway collapsibility and blunted genioglossus muscle activity in response to negative pharyngeal pressure. Anesthesiology 2009; 110:1253-1260.
9. Fuchs-Buder T, Meistelman C, Alla F, et al. Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine. Anesthesiology 2010; 112:34-40.
10. Reid JE, Breslin DS, Mirakhur RK, Hayes AH. Neostigmine antagonism of rocuronium block during anesthesia with sevoflurane, isoflurane or propofol. Can J Anesth 2001; 48:351-355. (Pubitemid 32479390)
11. Motamed C, Donati F. Sevoflurane and isoflurane, but not propofol, decrease mivacurium requirements over time. Can J Anesth 2002; 49:907-912. (Pubitemid 36097598)
12. Fuchs-Buder T, Claudius C, Skovgaard LT, et al. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand 2007; 51:789-808. (Pubitemid 47063004)
13. Fuchs-Buder T. Acceleromyography in research. In: Fuchs-Buder T, editor. Neuromuscular monitoring in clinical practice and research. Heidelberg, Germany: Springer Medizin Verlag; 2010. pp. 193-204.
14. Viby-Mogensen J. Neuromuscular monitoring. In: Miller RD, editor. Anesthesia, 5th ed. New York: Churchill-Livingstone; 1994. pp. 1351-1366.
15. Fuchs-Buder T, Schreiber JU, Meistelman C. Monitoring neuromuscular block: an update. Anaesthesia 2009; 64 (Suppl 1):82-89.
16. Lien CA. Neostigmine: how much is necessary for patients who receive a nondepolarizing neuromuscular blocking agent? Anesthesiology 2010; 112:6-8.
17. Payne JP, Hughes R, Al Azawi S. Neuromuscular blockade by neostigmine in anaesthetized man. Br J Anaesth 1980; 52:69-76. (Pubitemid 10203717)
18. Eikermann M, Fassbender P, Malhotra A, et al. Unwarranted administration of acetylcholinesterase inhibitors can impair genioglossus and diaphragm muscle function. Anesthesiology 2007; 107:621-629. (Pubitemid 47480569)
19. Herbstreit F, Zigrahn D, Ochterbeck C, et al. Neostigmine/glycopyrrolate administered after recovery from neuromuscular block increases upper airway collapsibility by decreasing genioglossus muscle activity in response to negative pharyngeal pressure. Anesthesiology 2010; 113:1280-1288.
20. Caldwell JE. Reversal of residual neuromuscular block with neostigmine at one to four hours after a single intubating dose of vecuronium. Anesth Analg 1995; 80:1168-1174.
21. Paul M, Fokt RM, Kindler CH, et al. Characterization of the interaction between volatile anesthetics and neuromuscular blockers at the muscle nicotinic acetylcholine receptor. Anesth Analg 2002; 95:362-367. (Pubitemid 34793101)
22. Stout RG, Gan TJ, Glass PS, et al. The effect of desflurane on rocuronium onset, clinical duration and maintenance requirements. Acta Anaesthesiol Belg 2006; 57:349-353. (Pubitemid 46087366)
23. Bock M, Kippel K, Nitsche B, et al. Rocuronium potency and recovery characteristics during steady-state desflurane, sevoflurane, isoflurane and propofol anaesthesia. Br J Anaesth 2000; 84:43-47. (Pubitemid 30009305)
24. Suzuki T, Munakata K, Watanabe N, et al. Augmentation of vecuroniuminduced neuromuscular block during sevoflurane anaesthesia: comparison with balanced anaesthesia using propofol or midazolam. Br J Anaesth 1999; 83:485-487. (Pubitemid 29412711)
25. Maidatsi PG, Zaralidou AT, Gorgias NK, et al. Rocuronium duration of action under sevoflurane, desflurane, or propofol anaesthesia. Eur J Anaesth 2004; 21:781-786. (Pubitemid 40288236)
26. Morita T, Tsukagoshi H, Sugaya T, et al. Inadequate antagonism of vecuronium-induced neuromuscular block by neostigmine during sevoflurane or isoflurane anaesthesia. Anesth Analg 1995; 80:1175-1180.
27. Kirkegaard H, Heier T, Caldwell JE. Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block. Anesthesiology 2002; 96:45-50. (Pubitemid 34032480)
28. Plaud B, Debaene B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology 2010; 112:1013-1022.
29. Baurin MJ, Dernovoi BS, D?Hollander AA, et al. Conditions to optimise the reversal action of neostigmine upon a vecuronium-induced neuromuscular block. Acta Anaesthesiol Scand 1996; 40:574-578. (Pubitemid 26183047)